CALT News

Four IPOs are expected to raise $2 billion before the Fourth of July, led by commercial data analytics provider Dun & Bradstreet (DNB). Dun & Bradstreet (DNB) plans to raise $1.3 billion at a market cap of $8 billion. The company was taken private for $6.9 billion including debt in February 2019 by an investor consortium led by Cannae Holdings,...read more

Calliditas Therapeutics, a Swedish biotech developing therapies for orphan kidney and liver diseases, raised $90 million in an upsized IPO by offering 4.6 million ADS equivalents at $19.50 per ADS. It originally planned to raise $75 million by offering 3.8 million ADS equivalents. Its last close on the Nasdaq Stockholm (CALTX) was SEK 93.90 per common share, or $20.40 per ADS ($1 =...read more

IPOs are once again gaining steam and the calendar is flush with deals. With the IPO Index near all-time highs (tracked by NYSE: IPO), there are now eight offerings slated to price, making it the busiest week of the year. ...read more

Calliditas Therapeutics, a Swedish biotech developing novel therapies for inflammatory kidney disease, announced terms for its IPO on Monday. The Stockholm, Sweden-based company plans to raise $75 million by offering 3.8 million ADSs at $19.77, the as-converted last close of its shares on the Nasdaq Stockholm. At the midpoint of the proposed range, Calliditas Therapeutics would...read more